Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Knowing when to switch from aggressive to conservative investing is key. Understand the signs that indicate it's time to adjust your strategy.
14,591 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
SK Hynix rode a Nasdaq debut to a turning point in AI hardware, with a $26.5 billion raise and 58% HBM market share. ...
Apple files a lawsuit against OpenAI over alleged trade-secrets theft. Jim Cramer calls the move heavyweight, signali...
Agentic AI changes how data centers think and act. This guide breaks down AMD, ARM, and Intel to identify the intel: ...
Garmin delivered a dominant Q4 with a big EPS beat and revenue surge, triggering a sharp market rally as investors we...
AMD just struck a landmark deal with a global AI cloud leader. This article breaks down what the contract means for r...
With prediction markets signaling a modest chance of beating estimates, Beyond Meat investors are weighing whether th...
Micron Technology soared 326% in just 12 months, but a sky-high gain doesn’t guarantee a smart buy. This guide breaks...
When high-growth stocks stumble after earnings, it sparks questions for investors. This article digs into why On Hold...
Smart investing isn’t about chasing the hottest story. It’s about owning durable businesses that quietly compound val...
Walmart beat Q4 estimates on earnings and revenue but guided FY27 growth below consensus, sparking bearish chatter fr...
Western Midstream Partners raised its quarterly distribution to $0.93 per unit, pushing the annualized payout to $3.7...